THORATEC CORP

Thoratec Corp., trading without a ticker, stands in the Electromedical & Electrotherapeutic Apparatus space and earns its stripes supplying implantable and external circulatory support systems, including ventricular assist devices, to hospitals and cardiac surgery centers confronting acute heart failure; these solutions marry precision engineering with patient monitoring to keep surgeons and intensivists in sync with post-operative needs, and the company leans on its SIC roots in medical instruments to underscore a legacy of regulatory compliance and clinical collaboration. With CIK 350907, Thoratec’s profile highlights that healthcare providers and large cardiovascular programs are its primary customers, relying on its technology to stabilize patients awaiting transplant or long-term therapy. Material risks remain tied to FDA approvals, reimbursement volatility, and the exacting standards of post-market surveillance in this capital-heavy segment, while macroeconomic pressure on hospitals can slow device adoption. The latest SEC disclosure is a Form 10-Q filed in November 1999, underscoring the importance of checking for fresh updates—view live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025